Table 1.

Experimental groups and dosing schedules of mouse LLC models (n = 6).

Group	Dosing schedule
Control	PBS (q3d., i.p.) + normal saline (q3d., i.v.) (d1–17)
Nab-PTX monotherapy	PBS (q3d., i.p.) + nab-PTX in normal saline (10 mg/kg, q3d., i.v.) (d1–17)
Anti-PD-1 antibody monotherapy	Anti-PD-1 antibody in PBS (200 μg, q3d., i.p.) + normal saline (q3d., i.v.) (d1–17)
Nab-PTX plus anti-PD-1 antibody	Anti-PD-1 antibody in PBS (200 μg, q3d., i.p.) + nab-PTX in normal saline (10 mg/kg, q3d., i.v.) (d1–17)